Hyperbilirubinemia, Neonatal
Conditions
Keywords
Hyperbilirubinemia, transcutaneous bilirubin, neonate
Brief summary
The goal of this observational study is to monitor the transcutaneous bilirubin (TCB) level in healthy near-term and full-term neonates from birth to 30 days of age across China. The main question it aims to answer is: Development of TcB Nomogram to Identify Neonatal Hyperbilirubinemia in Term and Late-preterm Infants Compare the changing trend of TCB among different areas in China Compare the changing trend of TCB among different gestational groups in China
Interventions
DEVICETranscutaneous bilirubin level monitoring
self-monitoring by parents long-term: from birth to 30 days of age
Sponsors
Guangzhou Women and Children's Medical Center
Neonatal-Infant Brain and Behavior Development Network
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
0 Days to 30 Days
Healthy volunteers
Yes
Inclusion criteria
Gestational age \>=35wk; did not admitted to hospital for any reason Less than 30 days of age
Exclusion criteria
Accept phototherapy within 60h of age
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Development of TcB Nomogram in Term and Late-preterm Infants from birth to 30 days of age | through study completion, an average of 1 year | From birth to 7 days of age, newborns should undergo transcutaneous bilirubin monitoring twice daily. From 8 to 14 days of age, jaundice should be monitored once daily, and from 14 to 30 days of age, monitoring should be done at least once every two days. |
Countries
China
Outcome results
None listed